Inhibition NLRP3 inflammasome using the specific inhibitor MCC950 has achieved satisfactory therapeutic results not only in ALI model but also other inflammatory conditions including autoimmune diseases [42]. This evidence concerns the gene NLRP3 and autoimmune disease.